Xoma | XOMA - Ebit

Stock Price
25.81
Daily Change
1.41 5.78%
Monthly
-5.35%
Yearly
9.74%
Q1 Forecast
25.01

Xoma reported $-10.08M in EBIT for its fiscal quarter ending in June of 2024.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Agenus USD -13.31M 19.08M Mar/2025
Agios Pharmaceuticals USD -121.58M 4.71M Dec/2025
Ardelyx USD 7.12M 19.62M Sep/2025
aTyr Pharma USD -226.49K 140.85K Sep/2025
BioMarin Pharmaceutical USD -31.69M 308.58M Sep/2025
Celldex Therapeutics USD -73.62M 9.76M Sep/2025
Curis USD -12.37M 230K Sep/2023
Eli Lilly USD 8.99B 1.57B Dec/2025
Incyte USD 383.88M 47.44M Dec/2025
MacroGenics USD 20.16M 55.51M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Novartis USD 4.48B 343M Sep/2025
Pfizer USD 4.65B 71M Dec/2025
Prothena USD -39.76M 12.25M Sep/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Xoma USD -10.08M 4.4M Jun/2024